Cargando…
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Anticancer immunotherapies, such as immune checkpoint inhibitors, bispecific antibodies, and chimeric antigen receptor T cells, have improved outcomes for patients with a variety of malignancies. However, most patients either do not initially respond or do not exhibit durable responses due to primar...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314654/ https://www.ncbi.nlm.nih.gov/pubmed/37399356 http://dx.doi.org/10.1136/jitc-2022-006533 |